Carmine Carpenito

Medicine · Health Sciences

28h-index9.1kcitations125works1.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(58), Cancer Immunotherapy and Biomarkers(43), Immunotherapy and Immune Responses(35), Immune Cell Function and Interaction(27), Monoclonal and Polyclonal Antibodies Research(21)

Publications124 total

Editor’s Note: Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
Cancer Research·2024· 1 citedOpen Access
Editor's Note: <i>In Vivo</i> Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)
Cancer Research·2024Open Access
Data from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Supplementary Data File from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Data from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Supplementary Data File from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Figure S8 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S6 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S3 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S9 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Table S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S4 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Table S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S3 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S7 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S8 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Supplemental Methods, Tables 1 - 3, Figures 1 - 16 from Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Carl H. June(23), Michael Kalos(15), Richard G. Carroll(11), Ruslan D. Novosiadly(11), Darin Chin(10), James L. Riley(9), Andreas Sonyi(9), Fumio Takei(8), Chrystal M. Paulos(7), John Scholler(7), David Schaer(7), Nelusha Amaladas(7), Erik Rasmussen(7), Andrew Capen(7), David Surguladze(7), Michael C. Milone(6), Jason R. Manro(6), Stephan A. Grupp(5), Steven Μ. Albelda(5), Daniel J. Powell(5)